NovaBay Pharmaceuticals Shifts Focus to Crypto, Rebrands as Stablecoin Development Corporation

Stablecoin Development Corporation, formerly NovaBay Pharmaceuticals, has announced a major shift in its business strategy. The company is rebranding to reflect its new focus on cryptocurrency and decentralized finance (DeFi).

The move signals a significant evolution in corporate crypto adoption, with firms increasingly engaging in yield-generating DeFi strategies rather than passive exposure.